Chief Officers
Dr. Camille M. Lange
Dr. Lange is a biomedical scientist and executive who leads complex initiatives at the intersection of science, regulatory strategy, quality and implementation. Her experience spans research, pharmaceutical and biologics development, biomedical laboratory systems, global health and market entry, with a focus on translating technical requirements into practical programs, partnerships and sustainable capacity.
Biomedical Laboratory Quality & Capacity Building
Drug, Vaccine & Biologics Development
Project Management & Program Implementation
Dr. Emmanuel K. Woode
Dr. Woode is a regulatory science and pharmaceutical quality executive with expertise spanning regulatory affairs, cGMP, CMC, quality systems and manufacturing oversight. He brings experience across investigational and commercial products, biologics and advanced therapeutics, helping organizations translate regulatory requirements into robust quality systems, inspection-ready operations and pathways to market.
cGMP, CMC & Pharmaceutical Quality Systems
Manufacturing & Facility Inspection Readiness
Biologics, Vaccines & Advanced Therapeutics
Mr. Ebenezer Egyepong
Mr. Egyepong is a pharmaceutical quality and analytical chemistry executive with two decades of experience leading pharmaceutical QC laboratories supporting commercial and clinical medicines. His expertise spans laboratory development and operations, analytical methods and validation, cGMP compliance, regulatory inspections, product release and laboratory systems, providing the technical and operational leadership required to build and sustain fit-for-purpose QC capability.
Analytical Methods, Validation & Technology Transfer
cGMP, Laboratory Compliance & Inspection Readiness
QC Instrumentation, LIMS & Laboratory Systems
Dr. Victor Ejigah
Dr. Ejigah is a pharmacist, regulatory strategist and pharmaceutical commercial executive with experience spanning global regulatory submissions, product development, market entry and international pharmaceutical supply. His work includes eCTD preparation, IND/NDA strategy and submission leadership, FDA interactions and marketed-product support, complemented by hands-on experience sourcing and importing pharmaceuticals across international markets and building pathways for products to reach patients.
Global Regulatory Strategy & Product Registration
Pharmaceutical Market Entry & Commercialization
International Sourcing, Supply & Partnerships
Dr. Danille Prime
Dr. Prime is a physician executive and clinical leader with experience spanning pulmonary and critical care medicine, medical leadership, clinical education, quality improvement and healthcare innovation. She brings frontline clinical perspective to the evaluation and implementation of medicines, technologies and health programs, connecting scientific and operational strategy with patient care and health-system needs.
Pulmonary & Critical Care Medicine
Clinical Quality, Ethics & Patient Care
Medical Education & Health-System Implementation
Ms. Sian Lange
Ms. Lange provides legal and business administration oversight for HENYIDA, supporting the agreements, governance and commercial arrangements that underpin the company’s partnerships and operations. Her work includes agreement review, contractual coordination and legal-administrative support to ensure that engagements move forward with clear responsibilities, appropriate documentation and sound governance.
Corporate Governance & Business Administration
Commercial & Partnership Agreements
Legal & Contractual Risk Coordination
